Receive Insights and Updates for Providers by email
The chart below identifies updates to our medical benefit drug program. For additional details, refer to the Medical Necessity Guidelines associated with the medical drug in question, which you can find on our Point32Health (the parent company of Harvard Pilgrim Health Care and Tufts Health Plan) Medical Benefit Drug Medical Necessity Guidelines page.
Alternatively, some medical drugs are managed through an arrangement with OncoHealth when utilized for oncology purposes for Harvard Pilgrim members. You can find information about this program on the OncoHealth page in the Vendor Programs section of Point32Health’s provider website and you can access the prior authorization policies for these drugs directly on OncoHealth’s webpage for Harvard Pilgrim.
Tufts Health Together utilizes MassHealth’s Unified Formulary for pharmacy medications and select medical benefit drugs; for drug coverage and criteria refer to the MassHealth Drug List.
New prior authorization programs for OncoHealth drugs | ||
| MNG/Drug(s) | Plan & additional information | Eff. date |
Ryoncil | Tufts Health Together
| 10/1/2026 |
Filkri (J3590) | Harvard Pilgrim Commercial New-to-market drug now subject to prior authorization/step therapy requirements. | 10/1/2026 |
Denosumab Samsung Bioepis (Ospomyv/Xbryk) (Q5159) | Harvard Pilgrim Commercial New-to-market drug now subject to prior authorization/step therapy requirements. | 10/1/2026 |
Vykoura (J3490) | Harvard Pilgrim Commercial New-to-market drug now subject to prior authorization/step therapy requirements. | 10/1/2026 |
Armlupeg (J3490) | Harvard Pilgrim Commercial New-to-market drug now subject to prior authorization/step therapy requirements. | 10/1/2026 |
| Blenrep | Harvard Pilgrim Commercial Blenrep (belantamab mafodotin-blmf, 0.1 mg) (J9037) will be covered when prior authorization has been obtained. | 10/1/2026 |
Updates to existing prior authorization programs | ||
| MNG/Drug(s) | Plan & additional information | Eff. date |
Epioxa | Tufts Health Together Prior authorization is now required for coverage of Epioxa (J2789), which will be covered when all the criteria specified by MassHealth are met. | 10/1/2026 |
Tufts Health Together MassHealth has made updates to the criteria for the following carve-out drugs:
| 10/1/2026 | |
| Carelon code list | Harvard Pilgrim Health Care Commercial, Tufts Health Direct, Tufts Health Plan Together, Tufts Health Plan RITogether, Tufts Health One Care The following codes are now covered with prior authorization:
| 10/1/2026 |